Atlas Trials

A Randomized, Double-Blind, Placebo-Controlled Trial of Flumazenil for the Treatment of Obsessive Compulsive Disorder

Clinical trial NCT00997087 · TERMINATED

Trial details

NCT number
NCT00997087
Sponsor
Parkway Medical Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Obsessive Compulsive Disorder
Start date
2009-10-01
Primary completion
2012-12-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.